Promotie onderzoek

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn23resultaten gevonden
Medicatieveiligheid

Specificity of medication surveillance (voorlopige titel)

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Jetske Graafsma
  • Promoters Patricia van den Bemt, Fatma Karapinar
  • Co-Promoters Joanna E. Klopotowska
  • Jaar 2024-2028
Medicatieveiligheid

Transitional care in geriatric patients

  • Universiteit Universiteit Utrecht
  • Promovendus Lotte Falke
  • Promoters Toine Egberts, Marcel Bouvy
  • Co-Promoters Fatma Karapinar, Wilma Knol
  • Jaar 2022-2028

Financiering UU/docentschap.
 

Medicatieveiligheid

Farmaceutische patiƫntenzorg

  • Universiteit Amsterdam Universitair Medisch Centrum
  • Promovendus Selma En-Nasery
  • Promoters Jacqueline Hugtenburg
  • Co-Promoters Fatma Karapinar, Pierre Bet
  • Jaar 2019-2025/2026
Onderwijs

Educating future prescribers - development of prescribing competenties in medical students and junior doctors

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Magali Heijkoop
  • Promoters Hugo van der Huy Andrea Woltman
  • Co-Promoters Floor van Rosse Jorie Versmissen
  • Jaar 2023-2026

We aim to explore and assess the development of prescribing competenties of medical students and junior doctors. We also evaluate how we can use innovative educational interventions to improve medication safety. 
 

Medicatieveiligheid

Optimizing therapy in patients suffering from statin-intolerance: n=1 trials.

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Ruben Mijnster
  • Promoters Hugo van der Kuy
  • Co-Promoters Melvin Lafeber Jeanine Roeters-van Lennep
  • Jaar 2024-2028

My research focuses on the occurence of nocebo-effects in statin-intolerant. We try to identify patients who are statin-intolerant and that suffer from these effects. We hope that by identifying patients affected by the nocebo effect and allowing them to experientially understand its impact through an N=1 study design, they will experience fewer side effects from their statin treatment. This may help prevent the need to switch to expensive PCSK9 inhibitors.
 

Medicatieveiligheid

Improving pharmaceutical care for hospitalized patients

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Sarah Wilkes
  • Promoters Hugo van der Kuy
  • Co-Promoters Rianne Zaal
  • Jaar 2022-2026

Cost benefit analysis clinical medication reviews. Follow up of interventions from clinical pharmacists. Medication information needs of hospitalized patients.
 

Onderwijs

Experience-based learning at pharmaceutical internships

  • Universiteit Leiden Universitair Medisch Centrum
  • Promovendus Rozita Abdolrahimi Raeni
  • Promoters Teun van Gelder
  • Co-Promoters Arianna Pranger
  • Jaar 2023-2026
Pagina 3 van 4